Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 50
Filtrar
1.
Clin Exp Dermatol ; 47(4): 717-723, 2022 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-34826142

RESUMO

BACKGROUND: The rare inversa subtype of recessive dystrophic epidermolysis bullosa (RDEB-I) is characterized by predominant intertriginous skin blistering and marked mucosal involvement. Specific recessive missense mutations in the collagen VII triple helix are implicated in the disease. To date, otological complications have been reported infrequently in this patient group. METHODS: We conducted an observational, retrospective, double institution case record review of patients with RDEB-I who presented with otological complications between January 2000 and June 2020. Diagnosis was established on the basis of clinical features, family history and mutation analysis of the COL7A1 gene. RESULTS: In total, 11 (44%) of 25 patients with RDEB-I in our database (2 paediatric, 9 adult; mean age 40.9 years, range 8-72 years) experienced otological complications. Of these 11 patients, 10 (90.9%) had recurrent otitis externa, 7 (63.6%) had meatal stenosis and 7 (63.6%) had recurrent blistering of the external auditory canals. All 11 patients reported hearing difficulties, with conductive hearing loss confirmed by audiology testing in 6 (54.5%) of these. Of the 11 patients, 3 (27.3%) went on to have implantable hearing aids [2 bone-anchored hearing aids (BAHA) and 1 middle ear implant (MEI)] fitted with favourable outcome, while a fourth paediatric patient presented with a cholesteatoma that was surgically managed. DISCUSSION: We observed a higher prevalence of otological morbidity in RDEB-I than previously reported, and present the first case of cholesteatoma in epidermolysis bullosa (EB). Our data indicate that BAHA and MEI are safe and effective treatment options for hearing loss in EB. Clinicians should be vigilant in screening for ear symptoms in RDEB-I and consider early referral to an Ear, Nose and Throat specialist.


Assuntos
Epidermólise Bolhosa Distrófica , Epidermólise Bolhosa , Adolescente , Adulto , Idoso , Criança , Colágeno Tipo VII/genética , Epidermólise Bolhosa/genética , Epidermólise Bolhosa Distrófica/complicações , Epidermólise Bolhosa Distrófica/genética , Genes Recessivos , Humanos , Pessoa de Meia-Idade , Mutação de Sentido Incorreto , Estudos Retrospectivos , Adulto Jovem
2.
J Eur Acad Dermatol Venereol ; 35(9): 1888-1895, 2021 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-34014582

RESUMO

BACKGROUND: Due to a large variety in treatment outcomes reported in therapeutic trials and lacking patient-relevant outcomes, it is hard to adequately compare and improve current therapies for patients with capillary malformations (CMs). The Core Outcome Set for Capillary Malformations (COSCAM) project aims to develop a core outcome set (COS) for use in future CM trials, in which we will first develop a core outcome (sub)domain set (CDS). Here, we describe the methods for the development of a CDS and present the results of the first development stage. METHODS: The COSCAM project is carried out according to the recommendations of the Cochrane Skin Core OUtcomes Set INitiative (CS-COUSIN) and the Core Outcome Measures in Effectiveness Trials (COMET) initiative. During the first stage, we identified all potentially relevant outcome subdomains based on a systematic review, two focus group sessions and input from patient representatives of Dutch patient organizations and the COSCAM-founding group. In stage two, we will present the subdomains in a three-round e-Delphi study and online consensus meeting, in which CM patients, parents/caregivers and CM experts worldwide rate the importance of the proposed subdomains, hereby finalizing the core outcome (sub)domains of the CDS. RESULTS: A total of 67 potential outcome subdomains were included; sixteen were previously used in the literature, 20 were proposed by Dutch patients and their parents/caregivers (n = 13) in focus group sessions and 38 were suggested by the experts of the COSCAM-founding group. Seven were excluded because of overlap. CONCLUSION: The final CDS may serve as a minimum standard in future CM trials, thereby facilitating adequate comparison of treatment outcomes. After this CDS development, we will select appropriate outcome measurement instruments to measure the core outcome subdomains.


Assuntos
Avaliação de Resultados em Cuidados de Saúde , Projetos de Pesquisa , Capilares/anormalidades , Técnica Delphi , Determinação de Ponto Final , Humanos , Revisões Sistemáticas como Assunto , Resultado do Tratamento , Malformações Vasculares
3.
Br J Dermatol ; 174(1): 56-67, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-26302137
8.
Clin Exp Dermatol ; 35(4): e100-2, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19874360

RESUMO

We describe the challenging case of a patient presenting with extensive, eruptive mid-facial squamous cell carcinomas (SCCs) and keratoacanthomas (KAs) consequent to radiotherapy. Our patient had a personal and family history of multiple KAs and SCCs. Multiple self-healing squamous epithelioma, otherwise known as Ferguson-Smith disease, was diagnosed. This case presented a therapeutic challenge to preserve tissue and avoid severe facial disfigurement. We found oral acitretin to be the treatment of choice.


Assuntos
Acitretina/uso terapêutico , Carcinoma de Células Escamosas/radioterapia , Neoplasias Faciais/radioterapia , Ceratoacantoma/radioterapia , Neoplasias Primárias Múltiplas/radioterapia , Neoplasias Cutâneas/radioterapia , Carcinoma de Células Escamosas/tratamento farmacológico , Carcinoma de Células Escamosas/patologia , Neoplasias Faciais/tratamento farmacológico , Neoplasias Faciais/patologia , Humanos , Ceratoacantoma/tratamento farmacológico , Ceratoacantoma/patologia , Ceratolíticos/uso terapêutico , Masculino , Pessoa de Meia-Idade , Neoplasias Primárias Múltiplas/tratamento farmacológico , Neoplasias Primárias Múltiplas/patologia , Neoplasias Induzidas por Radiação/tratamento farmacológico , Síndromes Neoplásicas Hereditárias/tratamento farmacológico , Síndromes Neoplásicas Hereditárias/patologia , Síndromes Neoplásicas Hereditárias/radioterapia , Neoplasias Cutâneas/tratamento farmacológico , Neoplasias Cutâneas/patologia
9.
Indian J Lepr ; 81(1): 1-4, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-20329361

RESUMO

Lagophthalmos is a well known complication in leprosy due to the involvement of seventh cranial nerve resulting in incomplete closure of the eyelids. The real magnitude of ocular morbidity as a consequence of lagophthalmos is unknown, as several ocular complications can occur independently due to involvement of the fifth (trigeminal) nerve or due to secondary infection. Therefore, a study was designed to carefully examine the eyes of 100 consecutive leprosy patients with lagophthalmos seeking treatment at a leprosy referral centre in Delhi. Among the eyes examined, 145 had lagophthalmos. The symptomatology and anterior-posterior chamber morbidity in eyes with lagophthalmos were significantly higher as compared to unaffected eyes. Significantly, higher morbidity was seen regardless of sex or type of leprosy or deformity. Capacity building of the health professionals regarding ocular morbidity and increased emphasis on the importance of self care among patients can significantly reduce ocular morbidity.


Assuntos
Doenças Palpebrais/microbiologia , Hanseníase Multibacilar/complicações , Hanseníase Paucibacilar/complicações , Estudos Transversais , Doenças Palpebrais/patologia , Feminino , Humanos , Índia , Hanseníase Multibacilar/microbiologia , Hanseníase Multibacilar/patologia , Hanseníase Paucibacilar/microbiologia , Hanseníase Paucibacilar/patologia , Masculino , Morbidade , Mycobacterium leprae , Acuidade Visual
10.
Mucosal Immunol ; 12(3): 720-732, 2019 05.
Artigo em Inglês | MEDLINE | ID: mdl-30651577

RESUMO

Inflammatory bowel disease (IBD) etiology involves genetic susceptibility, environmental triggers, and the gut microbiome. Antibiotic exposure is associated with IBD, both in early life and adulthood. Here, we investigated whether Nod2-deficiency influenced response of the gut microbiota to antibiotics and subsequent colitis susceptibility. Wild-type and Nod2-/- littermate mice were treated with amoxicillin as adults or neonates, and fecal samples were collected for 16S rRNA sequencing. Five weeks after antibiotic exposure, dextran sulfate sodium (DSS) colitis was induced. Antibiotic treatment altered the microbiota of adult WT and Nod2-/- mice, but recovery was delayed in Nod2-/- mice. Neonatal antibiotic treatment significantly changed the microbiota at weaning in WT and Nod2-/- littermates; however, Nod2-/- mice maintained reduced microbial diversity 14 days after cessation of antibiotics. Although treatment of adult mice did not influence susceptibility to colitis, neonatally treated Nod2-/- mice developed a more severe colitis. Moreover, the colitis phenotype was transferable through fecal transplantation into germ-free Nod2-/- recipients, and was associated with changes in intestinal T cells and the cytokine milieu following inflammation. These data demonstrate that neonatal antibiotic exposure has long-lasting influence on the microbiota and mucosal immunity, and may explain how NOD2 contributes to the risk of intestinal inflammation.


Assuntos
Amoxicilina/efeitos adversos , Antibacterianos/efeitos adversos , Colite/metabolismo , Microbioma Gastrointestinal/efeitos dos fármacos , Doenças Inflamatórias Intestinais/metabolismo , Proteína Adaptadora de Sinalização NOD2/metabolismo , Amoxicilina/administração & dosagem , Animais , Animais Recém-Nascidos , Antibacterianos/administração & dosagem , Colite/genética , Modelos Animais de Doenças , Suscetibilidade a Doenças , Transplante de Microbiota Fecal , Microbioma Gastrointestinal/fisiologia , Interação Gene-Ambiente , Humanos , Doenças Inflamatórias Intestinais/genética , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Proteína Adaptadora de Sinalização NOD2/genética , Risco
11.
Histopathology ; 52(3): 277-82, 2008 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-18081814

RESUMO

AIMS: To investigate the reactivity for oestrogen and progesterone receptors (ER and PR) in renal oncocytoma (RO) and chromophobe renal cell carcinoma (CHRCC). MATERIALS AND METHODS: Thirty-eight RO, 25 CHRCC, 20 papillary RCC with oncocytic cytoplasm and 10 clear cell RCC with dominant eosinophilic cytoplasm were submitted for immunohistochemistry for ER, PR, CD117 and RCC. RESULTS: All cases of RO and CHRCC displayed moderately positive reactivity for PR. The nuclear reactivity ranged from 60% to 90% in RO and from occasional cells to 70% in CHRCC. In CHRCC, reactivity tended to be more prevalent in areas of tumour cells with eosinophilic cytoplasm. Progesterone reactivity was focal in areas. All RO and most CHRCC were reactive for CD117 and neither RO nor CHRCC was reactive for RCC. CD117 reactivity tended to be more intense in CHRCC than in RO. Negative reactivity for CD117 and positive reactivity for RCC were observed in almost all RCC, as reported in the literature. CONCLUSIONS: PR can be used in combination with CD117 and RCC in the differential diagnosis of RO and eosinophilic variant of CHRCC with other RCC with oncocytic or eosinophilic cytoplasm.


Assuntos
Adenoma Oxífilo/metabolismo , Biomarcadores Tumorais/metabolismo , Carcinoma de Células Renais/metabolismo , Neoplasias Renais/metabolismo , Receptores de Progesterona/metabolismo , Adenoma Oxífilo/cirurgia , Carcinoma de Células Renais/cirurgia , Núcleo Celular/metabolismo , Núcleo Celular/patologia , Diagnóstico Diferencial , Feminino , Humanos , Técnicas Imunoenzimáticas , Neoplasias Renais/cirurgia , Masculino , Proteínas Proto-Oncogênicas c-kit/metabolismo , Receptores de Estrogênio/metabolismo
12.
Endocr Connect ; 7(12): 1442-1447, 2018 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-30475222

RESUMO

Aims Physical activity has been proposed to be an effective non-pharmacological method of reducing systemic inflammation and therefore may prove particularly efficacious for women with polycystic ovary syndrome (PCOS) who have been shown to have high levels of inflammation and an increased risk of type 2 diabetes (T2DM) and cardiovascular disease (CVD). Therefore, the aim of the present study was to assess whether modest changes in daily step count could significantly reduce levels of inflammatory markers in women with PCOS. Subjects and Methods Sixty-five women with PCOS were assessed at baseline and again at 6 months. All had been provided with an accelerometer and encouraged to increase activity levels. Multivariate linear regression analyses (adjusted for age, ethnicity, baseline step count, change in BMI and change in accelerometer wear-time) were used to assess changes in daily step count against clinical and research biomarkers of inflammation, CVD and T2DM. Results Mean step count/day at baseline was 6337 (±270). An increase in step count (by 1000 steps) was associated with a 13% reduction in IL6 (ß: -0.81 ng/L; 95% CI, -1.37, -0.25, P = 0.005) and a 13% reduction in CRP (ß: -0.68 mg/L; 95% CI, -1.30, -0.06, P = 0.033). Additionally, there was a modest decrease in BMI (ß: 0.20 kg/m2; 95% CI, -0.38, -0.01, P = 0.038). Clinical markers of T2DM and CVD were not affected by increased step count. Conclusions Modest increases in step count/day can reduce levels of inflammatory markers in women with PCOS, which may reduce the future risk of T2DM and CVD.

13.
Anaesth Intensive Care ; 45(1): 92-93, 2017 01.
Artigo em Inglês | MEDLINE | ID: mdl-28072941

RESUMO

Herein we detail the cases of three patients transferred on veno-arterial extracorporeal membrane oxygenation (VA ECMO) from a tertiary referral hospital to an ECMO centre. We highlight the benefits of such a transfer and offer this as a model of care for unwell patients likely to require a prolonged period of ECMO support.


Assuntos
Oxigenação por Membrana Extracorpórea/métodos , Transferência de Pacientes , Adulto , Austrália , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Centros de Atenção Terciária , Fatores de Tempo
14.
Curr Opin Neurobiol ; 11(3): 378-86, 2001 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-11399438
15.
Gene ; 155(1): 27-34, 1995 Mar 21.
Artigo em Inglês | MEDLINE | ID: mdl-7698664

RESUMO

We have identified and sequenced four genes that encode the protein subunits comprising the succinate dehydrogenase enzyme complex (Sdh) of the rickettsia Coxiella burnetii. The Sdh-encoding gene cluster (sdhCDAB) begins 3326 bp upstream from the citrate synthase-encoding gene (gltA) start codon and is read with opposite polarity. An open reading frame encoding the N-terminal 280 amino acids (aa) of 2-oxoglutarate dehydrogenase (SucA) begins 24 bp downstream from the stop codon of the gene specifying the iron-sulfur subunit (sdhB) of Sdh. The deduced aa sequence of Sdh subunits and the N-terminal portion of SucA revealed significant aa identity with the Esherichia coli homologues ranging from a low of 36.6% for SdhD to a high of 61.2% for SdhA and SdhB. Primer extension identified transcription start points (tsp) for sdh and sucA. The region upstream from the sdh tsp, but not the sucA tsp, displayed homology to promoter consensus sequences of E. coli. Further evidence that sucA transcription can occur independent of sdh transcription was provided by demonstrating that a TnphoA insertion disrupting sdhB had no effect on the production of SucA by an E. coli cell-extract-directed in vitro transcription/translation system. The plasmid clone pLPM60, which carries the C. burnetii sdhCDAB coding and upstream regulatory regions, rescued an E. coli sdhA mutant (MOB252), indicating functional expression of the rickettsial locus. A cell extract of MOB252 transformed with pLPM60 showed a sixfold greater level of Sdh enzyme activity over the E. coli wild type. A plasmid clone lacking the sdh upstream regulatory region did not complement nor produce sdh mRNA by dot blot analysis.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Coxiella burnetii/genética , Genes Bacterianos , Família Multigênica , Succinato Desidrogenase/genética , Sequência de Aminoácidos , Sequência de Bases , Coxiella burnetii/enzimologia , Escherichia coli , Regulação Bacteriana da Expressão Gênica , Regulação Enzimológica da Expressão Gênica , Dados de Sequência Molecular , Biossíntese de Proteínas , Proteínas Recombinantes/biossíntese , Succinato Desidrogenase/biossíntese , Transcrição Gênica
16.
Int J Radiat Oncol Biol Phys ; 50(2): 317-23, 2001 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-11380217

RESUMO

PURPOSE: Accurate spatial representation of tumor clearance after conformal radiotherapy is an endpoint of clinical importance. Magnetic resonance spectroscopy (MRS) can diagnose malignancy in the untreated prostate gland through measurements of cellular metabolites. In this study we sought to describe spectral metabolic changes in prostatic tissue after radiotherapy and validate a multivariate analytic strategy (based on MRS) that could identify viable tumor. METHODS AND MATERIALS: Transrectal ultrasound-guided prostate biopsies from 35 patients were obtained 18-36 months after external beam radiotherapy. One hundred sixteen tissue specimens were subjected to 1H MRS, submitted to histopathology, and analyzed for correlation with a multivariate strategy specifically developed for biomedical spectra. RESULTS: The sensitivity and specificity of MRS in identifying a malignant biopsy were 88.9% and 92% respectively, with an overall classification accuracy of 91.4%. The diagnostic spectral regions identified by our algorithm included those due to choline, creatine, glutamine, and lipid. Citrate, an important discriminating resonance in the untreated prostate gland, was invisible in all spectra, regardless of histology. CONCLUSIONS: Although the spectral features of prostate tissue markedly change after radiotherapy, MRS combined with multivariate methods of analysis can accurately identify histologically malignant biopsies. MRS shows promise as a modality that could integrate three-dimensional measures of tumor response.


Assuntos
Espectroscopia de Ressonância Magnética/métodos , Neoplasias da Próstata/metabolismo , Neoplasias da Próstata/radioterapia , Idoso , Biópsia , Humanos , Masculino , Análise Multivariada , Estadiamento de Neoplasias , Neoplasias da Próstata/patologia , Radioterapia Conformacional , Reprodutibilidade dos Testes , Sensibilidade e Especificidade
17.
Neuropharmacology ; 36(9): 1253-68, 1997 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-9364480

RESUMO

The properties of central ATP-mediated synaptic currents were studied using whole-cell patch-clamp recording in rat medial habenula slices. Release was shown to be calcium dependent with a Hill coefficient of approximately 2. The voltage dependence of synaptic current amplitudes was approximately linear. Some reduction of the synaptic current amplitudes was observed at 10 mM extracellular calcium, suggesting calcium block/permeability of the channels. This was confirmed by observation of current-voltage reversal potentials in different calcium concentrations. We estimate that the channels underlying half the synapses showed a negligible calcium permeability. In the other four out of eight synapses the results suggest a very high calcium permeability with an estimated PCa/PCs of > 10. Thus, at -70 mV, in 1 mM calcium, more than 15% of the ATP-mediated synaptic current is estimated to be carried by calcium, but only at synapses with calcium-permeable channels. Net current through these synaptic channels is also controlled by the voltage dependence of synaptic current decay time constants (increasing e-fold for 158 mV depolarization) and by a strong dependence of transmitter release on the frequency of stimulation of the presynaptic neurone, with failure rates increasing 3-fold as stimulation rates were increased from 1 to 10 Hz.


Assuntos
Habenula/fisiologia , Receptores Purinérgicos P2/fisiologia , Transmissão Sináptica/efeitos dos fármacos , Animais , Cálcio/farmacologia , Canais de Cálcio/farmacologia , Feminino , Habenula/efeitos dos fármacos , Técnicas In Vitro , Masculino , Técnicas de Patch-Clamp , Ratos , Receptores Purinérgicos P2/efeitos dos fármacos
18.
Br J Pharmacol ; 108(1): 170-8, 1993 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-7679027

RESUMO

1. The patch-clamp technique was used to examine levamisole-activated channels in muscle vesicles from Ascaris suum. Cell-attached and isolated inside-out patches were used. 2. Levamisole (1-90 microM), applied to the extracellular surface, activated channels which had apparent mean open-times in the range 0.80-2.85 ms and linear I/V relationships with conductances in the range 19-46 pS. Ion-replacement experiments showed the channels to be cation selective. 3. The kinetics of the channels were analysed. Generally open- and closed-time distributions were best fitted by two, and three exponentials respectively, indicating the presence of at least two open states and at least three closed states. The distributions of burst-times were best-fitted by two exponentials. 4. Channel open- and burst-times were voltage-sensitive: at low levamisole concentrations (1-10 microM), they increased with hyperpolarization. At higher concentrations of levamisole (30 microM and 90 microM) flickering channel-block was observed at hyperpolarized potentials. Using a simple channel-block model, values for the blocking dissociation constant, KB were determined as 123 microM at -50 mV, 46 microM at -75 mV and 9.4 microM at -100 mV. 5. At the higher concentration of levamisole (30 microM and 90 microM) long closed-times separating 'clusters' of bursts were observed, at both hyperpolarized and depolarized membrane potentials and this was interpreted as desensitization.


Assuntos
Ascaris suum/efeitos dos fármacos , Canais Iônicos/efeitos dos fármacos , Levamisol/farmacologia , Animais , Ascaris suum/metabolismo , Canais Iônicos/fisiologia , Cinética , Potenciais da Membrana/efeitos dos fármacos , Músculos/efeitos dos fármacos , Músculos/metabolismo
19.
Br J Pharmacol ; 118(4): 951-6, 1996 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-8799567

RESUMO

1. The electrophysiological actions of the P2-purinoceptor agonists, adenosine 5'-triphosphate (ATP), 2-methylthio ATP (2-meSATP) and alpha, beta-methyleneATP (alpha, beta-meATP) and of uridine 5'-triphosphate (UTP) were studied under concentration and voltage-clamp conditions in dissociated neurones of 1-6 day old rat dorsal root ganglia. 2. ATP (10 nM-100 microM) applied rapidly via a U-tube perfusion system (equilibration time < 10 ms) activated concentration-dependent inward currents with a latency to onset of a few ms, an EC50 of 719 nM and a Hill slope of 1.47. 3. 2-meSATP (10 nM- 100 microM) and alpha, beta-meATP (100 nM - 100 microM) also evoked transient inward currents. The EC50 and Hill slopes were 450 nM and 1.58 for 2-meSATP and 1.95 microM and 1.53 for alpha, beta-meATP respectively. There was no significant difference between the maximum currents evoked by the three agonists. 4. As the concentration of ATP increased so the rate of rise and decay of the currents also increased. At 100 and 300 nM ATP the decay of the current was best fitted by a single exponential, but at 1 microM and above two exponentials were required. Log-log plots of the rise time or time constants of decay versus concentration were linear. Currents evoked by 2-meSATP and alpha, beta-meATP showed a similar concentration-dependence in their kinetics. 5. Inward currents evoked by ATP, 2-meSATP and alpha, beta-meATP (300 nM) were abolished by the P2-purinoceptor antagonist, suramin (100 microM). 6. UTP (10 microM) evoked similar transient inward currents, which were sensitive to suramin (100 microM). ATP (10 microM), applied 2 min beforehand, reduced the response to UTP (10 microM) by 80 +/- 10%. 7. This study shows that ATP, 2-meSATP and alpha, beta-meATP act via a suramin-sensitive P2x-purinoceptor to evoke rapid, transient inward currents in dissociated neurones of rat dorsal root ganglia. The pyrimidine nucleotide, UTP, was also active. It is likely that the agonists were acting at the P2x3-subtype to produce these effects.


Assuntos
Trifosfato de Adenosina/farmacologia , Gânglios Espinais/efeitos dos fármacos , Receptores Purinérgicos P2/genética , Animais , Relação Dose-Resposta a Droga , Eletrofisiologia , Gânglios Espinais/fisiologia , Potenciais da Membrana/efeitos dos fármacos , Técnicas de Patch-Clamp , Antagonistas do Receptor Purinérgico P2 , Ratos , Receptores Purinérgicos P2/fisiologia , Suramina/farmacologia , Uridina Trifosfato/farmacologia
20.
Hum Pathol ; 22(12): 1294-5, 1991 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-1748436

RESUMO

This is the first reported case in the English literature of malacoplakia of the liver. In common with other cases of malacoplakia, the patient was immunosuppressed secondary to steroid therapy for underlying systemic lupus erythematosus. The patient died 18 months after presentation; at autopsy, the histologic features included those of the late or fibrous stage of malacoplakia.


Assuntos
Hepatopatias/patologia , Malacoplasia/patologia , Feminino , Humanos , Hospedeiro Imunocomprometido , Microscopia Eletrônica , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA